Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel

NCT05776160 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Large B-cell Lymphoma
Follicular Lymphoma

Interventions

DRUG: Axicabtagene Ciloleucel

Sponsor

Kite, A Gilead Company